Georgia Erbez
2021 - Harpoon Therapeutics
In 2021, Georgia Erbez earned a total compensation of $2.2M as Former Chief Financial Officer at Harpoon Therapeutics, a 118% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $203,550 |
|---|---|
| Option Awards | $1,599,386 |
| Salary | $415,000 |
| Other | $9,711 |
| Total | $2,227,647 |
Erbez received $1.6M in option awards, accounting for 72% of the total pay in 2021.
Erbez also received $203.6K in non-equity incentive plan, $415K in salary and $9.7K in other compensation.
Rankings
In 2021, Georgia Erbez's compensation ranked 5,621st out of 12,415 executives tracked by ExecPay. In other words, Erbez earned more than 54.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,621 out of 12,415 | 55th |
Division Manufacturing | 2,384 out of 5,505 | 57th |
Major group Chemicals And Allied Products | 1,037 out of 2,375 | 56th |
Industry group Drugs | 926 out of 2,096 | 56th |
Industry Biological Products, Except Diagnostic Substances | 226 out of 449 | 50th |
Source: SEC filing on April 27, 2023.
Erbez's colleagues
We found three more compensation records of executives who worked with Georgia Erbez at Harpoon Therapeutics in 2021.